Clinical Trials Browser

Phase 3 × 177Lu-octreotide, DOTA(0)-Tyr(3)- × 1 year × Clear all

NCT05918302 2026-05-12

LEVEL

Phase 3 Recruiting

Thymus Neoplasms, Neuroendocrine Tumors

NCT03049189 2026-04-06

COMPETE

Phase 3 Active not recruiting

324 enrolled 15 charts

Neuroendocrine Tumors

NCT04919226 2025-09-10

COMPOSE

Phase 3 Active not recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT05387603 2025-09-10

START-NET

Phase 3 Recruiting

Neuroendocrine Tumors